---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-289289"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2022-11-21T23:59:59+00:00"
generated_at: "2026-06-21T15:28:21.960343+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Orthofix and SeaSpine name leadership team for combined company; John Bostjancic as CFO

## Summary
- Merger of equals expected to close Q1 2023, subject to shareholder approvals.
- John Bostjancic (SeaSpine CFO/COO) to serve as CFO of combined company post-closing.
- Keith Valentine (SeaSpine CEO) to be CEO; Jon Serbousek (Orthofix CEO) to be Executive Chairman.
- Full Executive Leadership Team announced, including presidents for orthopedics, spine, biologics, enabling technologies.
- Doug Rice (Orthofix CFO) will assist with integration transition after close.

## SEC filing metadata
- accession: 0001193125-22-289289
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2022-11-21T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000119312522289289/0001193125-22-289289-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000119312522289289/d407957d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-289289
- JSON: https://secwatch.observer/filing/0001193125-22-289289.json
- Plain text: https://secwatch.observer/filing/0001193125-22-289289.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.